Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 273 No 7312 p237
14 August 2004


Society summary


CHRE cites Society’s “noteworthy” practice

The Society’s activities in support of new roles for pharmacists and the roll-out of its continuing professional development mechanisms have been cited as examples of noteworthy practice in the first annual performance review of the Society by the Council for Healthcare Regulatory Excellence (officially the Council for the Regulation of Health Care Professionals).

The review, reported to the August Council meeting, also cites as noteworthy the Society’s dissemination of a wide range of up-to-date publications building on science, evidence-based practice and ethical advice.

In its conclusions, the review notes that the Society is still waiting for changes under a Section 60 Order under the Heath Act 1999, and hopes that the proposed changes will be published by late summer for implementation early in 2005. It also notes that the Society incurs additional costs in complying with CHRE needs.

It says that the Society has highlighted a need for cross-notification between regulators when a practitioner is removed from a professional register.

And it says that corporate ownership of pharmacies raises issues, with the Society needing more effective powers, such as greater control over premises or strengthened powers for superintendent pharmacists. It adds that the Society has problems dealing with a situation where a pharmacist owner of a business who has been erased from the register continues to have a hand in the business.

Back to Top


©The Pharmaceutical Journal